Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion description "[Together, these observations suggest that activation of CRLF2 expression, mutation of JAK kinases, and alterations of IKZF1 cooperate to promote B-cell leukemogenesis and identify these pathways as important therapeutic targets in this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion evidence source_evidence_literature NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion SIO_000772 20139093 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion wasDerivedFrom befree-20140225 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_assertion wasGeneratedBy ECO_0000203 NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP514792.RAceldWsOO8BwD2eN7E-EnrK9ezEupwvNf19VqP9XQLJo130_provenance.